Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3P9G

Crystal structure of the TSG101 UEV domain in complex with FA459 peptide

Summary for 3P9G
Entry DOI10.2210/pdb3p9g/pdb
Related3OBQ 3P9H
DescriptorTumor susceptibility gene 101 protein, Gag polyprotein (3 entities in total)
Functional Keywordsprotein transport, ubiquitin
Biological sourceHomo sapiens (human)
More
Cellular locationCytoplasm: Q99816
Matrix protein p17: Virion (By similarity): Q9YP46
Total number of polymer chains2
Total formula weight17585.30
Authors
Hurley, J.H.,Im, Y.J. (deposition date: 2010-10-17, release date: 2011-06-29, Last modification date: 2023-12-06)
Primary citationKim, S.E.,Liu, F.,Im, Y.J.,Stephen, A.G.,Fivash, M.J.,Waheed, A.A.,Freed, E.O.,Fisher, R.J.,Hurley, J.H.,Burke, T.R.
Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands.
ACS Med Chem Lett, 2:337-341, 2011
Cited by
PubMed Abstract: Targeting protein-protein interactions is gaining greater recognition as an attractive approach to therapeutic development. An example of this may be found with the human cellular protein encoded by the tumor susceptibility gene 101 (Tsg101), where interaction with the p6 C-terminal domain of the nascent viral Gag protein is required for HIV-1 particle budding and release. This association of Gag with Tsg101 is highly dependent on a "Pro-Thr-Ala-Pro" ("PTAP") peptide sequence within the p6 protein. Although p6-derived peptides offer potential starting points for developing Tsg101-binding inhibitors, the affinities of canonical peptides are outside the useful range (K(d) values greater than 50 μM). Reported herein are crystal structures of Tsg101 in complex with two structurally-modified PTAP-derived peptides. This data define new regions of ligand interaction not previously identified with canonical peptide sequences. This information could be highly useful in the design of Tsg101-binding antagonists.
PubMed: 21643473
DOI: 10.1021/ml1002579
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon